Document Detail


Resting energy expenditure at 3 months of age following neonatal surgery for congenital heart disease.
MedLine Citation:
PMID:  23360096     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Infants with Congenital Heart Disease (CHD) often exhibit growth failure. This can affect anthropometric and neurodevelopmental outcomes well into childhood. To determine the resting energy expenditure (REE), body composition, and growth in infants with CHD at 3 months of age, with the secondary aim to identify predictors of REE as compared with healthy infants.
DESIGN AND METHODS: This descriptive study is a subanalysis of a prospective study investigating predictors of growth in postoperative infants with CHD compared with healthy infants. Growth measurements, REE, and body composition were obtained in all infants. Analysis included chi-square for association between categorical variables, t-tests, ANOVA and ANCOVA. Outcome measures included the REE as determined by indirect calorimetry, anthropometric z-scores and body composition at 3 months of age.
SETTING: Participants were recruited from the Cardiac Intensive Care Unit of a large, urban, pediatric cardiac center and pediatric primary care practices.
RESULTS: The analysis included 93 infants, 44 (47%) with CHD. Of the infants with CHD, 39% had single ventricle (SV) physiology. There was no difference in REE related to cardiac physiology between infants with CHD and healthy infants or between infants with SV and biventricular (BV) physiology. Anthropometric z-scores for weight (-1.1 ± 1.1, P < 0.001), length (-0.7 ± 1.1, P < 0.05), and head circumference (-0.6 ± 1.2, P < 0.001) were lower in infants with CHD at 3 months of age. The percentage of body fat (%FAT) in postoperative infants with SV (24% ± 6, P = 0.02) and BV (23% ± 5, P < 0.001) physiology were lower than in healthy infants (27% ± 5), with no difference in REE.
CONCLUSION: At 3 months of age, there was no difference in REE between postsurgical infants with CHD and healthy infants. Infants with CHD had lower growth z-scores and %FAT. These data demonstrate decreased %FAT contributed to growth failure in the infants with CHD.
Authors:
Sharon Y Irving; Barbara Medoff-Cooper; Nicole O Stouffer; Joan I Schall; Chitra Ravishankar; Charlene W Compher; Bradley S Marino; Virginia A Stallings
Related Documents :
25017406 - Reappraisal of twinning: epidemiology and outcome in the early neonatal period.
4053646 - A noninvasive constant-flow method for measuring respiratory compliance in newborn infa...
19242486 - State of the art in conventional mechanical ventilation.
23250096 - Prevalence and factors associated with thoracic alterations in infants born prematurely.
2072886 - Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.
1006156 - Prevalence of antral and fundic gastritis in a randomly selected group of an estonian r...
Publication Detail:
Type:  Journal Article     Date:  2013-01-30
Journal Detail:
Title:  Congenital heart disease     Volume:  8     ISSN:  1747-0803     ISO Abbreviation:  Congenit Heart Dis     Publication Date:    2013 Jul-Aug
Date Detail:
Created Date:  2013-07-23     Completed Date:  2014-02-26     Revised Date:  2014-07-02    
Medline Journal Info:
Nlm Unique ID:  101256510     Medline TA:  Congenit Heart Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  343-51     Citation Subset:  IM    
Copyright Information:
© 2013 Wiley Periodicals, Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adiposity
Age Factors
Analysis of Variance
Body Height
Body Weight
Calorimetry, Indirect
Cardiac Surgical Procedures* / adverse effects
Case-Control Studies
Cephalometry
Chi-Square Distribution
Child Development
Energy Metabolism*
Female
Growth Disorders / etiology,  metabolism,  physiopathology
Head / growth & development
Heart Defects, Congenital / metabolism,  surgery*
Hospitals, Pediatric
Humans
Infant
Linear Models
Male
Philadelphia
Primary Health Care
Prospective Studies
Rest*
Risk Factors
Treatment Outcome
Grant Support
ID/Acronym/Agency:
M01 RR000240/RR/NCRR NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A chemical complementation approach reveals genes and interactions of flavonoids with other pathways...
Next Document:  Phenolic profile and antioxidant capacity of the principal apples produced in Brazil.